These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 34782454)

  • 1. Desmosterol suppresses macrophage inflammasome activation and protects against vascular inflammation and atherosclerosis.
    Zhang X; McDonald JG; Aryal B; Canfrán-Duque A; Goldberg EL; Araldi E; Ding W; Fan Y; Thompson BM; Singh AK; Li Q; Tellides G; Ordovás-Montanes J; García Milian R; Dixit VD; Ikonen E; Suárez Y; Fernández-Hernando C
    Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34782454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p38δ MAPK: A Novel Regulator of NLRP3 Inflammasome Activation With Increased Expression in Coronary Atherogenesis.
    Rajamäki K; Mäyränpää MI; Risco A; Tuimala J; Nurmi K; Cuenda A; Eklund KK; Öörni K; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1937-46. PubMed ID: 27417584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dehydrocholesterol Reductase 24 (DHCR24): Medicinal Chemistry, Pharmacology and Novel Therapeutic Options.
    Müller C; Hank E; Giera M; Bracher F
    Curr Med Chem; 2022; 29(23):4005-4025. PubMed ID: 34781860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How essential is cholesterol?
    Stevenson J; Brown AJ
    Biochem J; 2009 May; 420(2):e1-4. PubMed ID: 19426142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmosterol can replace cholesterol in sustaining cell proliferation and regulating the SREBP pathway in a sterol-Delta24-reductase-deficient cell line.
    Rodríguez-Acebes S; de la Cueva P; Fernández-Hernando C; Ferruelo AJ; Lasunción MA; Rawson RB; Martínez-Botas J; Gómez-Coronado D
    Biochem J; 2009 May; 420(2):305-15. PubMed ID: 19260826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage-Derived 25-Hydroxycholesterol Promotes Vascular Inflammation, Atherogenesis, and Lesion Remodeling.
    Canfrán-Duque A; Rotllan N; Zhang X; Andrés-Blasco I; Thompson BM; Sun J; Price NL; Fernández-Fuertes M; Fowler JW; Gómez-Coronado D; Sessa WC; Giannarelli C; Schneider RJ; Tellides G; McDonald JG; Fernández-Hernando C; Suárez Y
    Circulation; 2023 Jan; 147(5):388-408. PubMed ID: 36416142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Nlrp3 inflammasomes enhances macrophage lipid-deposition and migration: implication of a novel role of inflammasome in atherogenesis.
    Li X; Zhang Y; Xia M; Gulbins E; Boini KM; Li PL
    PLoS One; 2014; 9(1):e87552. PubMed ID: 24475307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid LXR (Liver X Receptor) Deficiency Induces Inflammatory Gene Expression in Foamy Macrophages and Accelerates Atherosclerosis.
    Endo-Umeda K; Kim E; Thomas DG; Liu W; Dou H; Yalcinkaya M; Abramowicz S; Xiao T; Antonson P; Gustafsson JÅ; Makishima M; Reilly MP; Wang N; Tall AR
    Arterioscler Thromb Vasc Biol; 2022 Jun; 42(6):719-731. PubMed ID: 35477277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage Lxrα reduces atherosclerosis in Ldlr
    Yin Y; Zeng S; Li Y; Wu Z; Huang D; Gao P
    Biochem Biophys Res Commun; 2020 Aug; 529(3):540-547. PubMed ID: 32736671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-specific discrimination of desmosterol and desmosterol mimetics confers selective regulation of LXR and SREBP in macrophages.
    Muse ED; Yu S; Edillor CR; Tao J; Spann NJ; Troutman TD; Seidman JS; Henke A; Roland JT; Ozeki KA; Thompson BM; McDonald JG; Bahadorani J; Tsimikas S; Grossman TR; Tremblay MS; Glass CK
    Proc Natl Acad Sci U S A; 2018 May; 115(20):E4680-E4689. PubMed ID: 29632203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis.
    Freigang S; Ampenberger F; Spohn G; Heer S; Shamshiev AT; Kisielow J; Hersberger M; Yamamoto M; Bachmann MF; Kopf M
    Eur J Immunol; 2011 Jul; 41(7):2040-51. PubMed ID: 21484785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses.
    Spann NJ; Garmire LX; McDonald JG; Myers DS; Milne SB; Shibata N; Reichart D; Fox JN; Shaked I; Heudobler D; Raetz CR; Wang EW; Kelly SL; Sullards MC; Murphy RC; Merrill AH; Brown HA; Dennis EA; Li AC; Ley K; Tsimikas S; Fahy E; Subramaniam S; Quehenberger O; Russell DW; Glass CK
    Cell; 2012 Sep; 151(1):138-52. PubMed ID: 23021221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desmosterol and DHCR24: unexpected new directions for a terminal step in cholesterol synthesis.
    Zerenturk EJ; Sharpe LJ; Ikonen E; Brown AJ
    Prog Lipid Res; 2013 Oct; 52(4):666-80. PubMed ID: 24095826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bifunctional supramolecular nanofiber inhibits atherosclerosis by enhancing plaque stability and anti-inflammation in apoE
    Shang Y; Ma C; Zhang J; Wang Z; Ren C; Luo X; Peng R; Liu J; Mao J; Shi Y; Fan G
    Theranostics; 2020; 10(22):10231-10244. PubMed ID: 32929345
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the cholesterol-free mouse: strong activation of LXR-regulated hepatic genes when replacing cholesterol with desmosterol.
    Heverin M; Meaney S; Brafman A; Shafir M; Olin M; Shafaati M; von Bahr S; Larsson L; Lövgren-Sandblom A; Diczfalusy U; Parini P; Feinstein E; Björkhem I
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2191-7. PubMed ID: 17761942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rutaecarpine derivative R3 attenuates atherosclerosis via inhibiting NLRP3 inflammasome-related inflammation and modulating cholesterol transport.
    Luo J; Wang X; Jiang X; Liu C; Li Y; Han X; Zuo X; Li Y; Li N; Xu Y; Si S
    FASEB J; 2020 Jan; 34(1):1398-1411. PubMed ID: 31914630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Andrographolide Attenuates Oxidized LDL-Induced Activation of the NLRP3 Inflammasome in Bone Marrow-Derived Macrophages and Mitigates HFCCD-Induced Atherosclerosis in Mice.
    Chen CC; Lii CK; Liu KL; Lin YL; Lo CW; Li CC; Yang YC; Chen HW
    Am J Chin Med; 2023; 51(8):2175-2193. PubMed ID: 37930331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgE Contributes to Atherosclerosis and Obesity by Affecting Macrophage Polarization, Macrophage Protein Network, and Foam Cell Formation.
    Zhang X; Li J; Luo S; Wang M; Huang Q; Deng Z; de Febbo C; Daoui A; Liew PX; Sukhova GK; Metso J; Jauhiainen M; Shi GP; Guo J
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):597-610. PubMed ID: 31996021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ClC-2 inhibition prevents macrophage foam cell formation by suppressing Nlrp3 inflammasome activation.
    Ding W; Li J; Wang L; Zhang M; Zheng F
    Biosci Biotechnol Biochem; 2020 Oct; 84(10):2096-2103. PubMed ID: 32657644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin Ameliorates the Progression of Atherosclerosis via Mitophagy Activation and NLRP3 Inflammasome Inhibition.
    Ma S; Chen J; Feng J; Zhang R; Fan M; Han D; Li X; Li C; Ren J; Wang Y; Cao F
    Oxid Med Cell Longev; 2018; 2018():9286458. PubMed ID: 30254716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.